SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-033285
Filing Date
2023-04-27
Accepted
2023-04-27 16:26:33
Documents
14
Period of Report
2023-04-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea177537-8k_avalon.htm   iXBRL 8-K 42537
2 PRESS RELEASE ISSUED BY THE COMPANY, DATED APRIL 27, 2023 ea177537ex99-1_avalon.htm EX-99.1 50145
6 GRAPHIC ex99-1_001.jpg GRAPHIC 3034
  Complete submission text file 0001213900-23-033285.txt   280255

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE albt-20230426.xsd EX-101.SCH 2983
4 XBRL LABEL FILE albt-20230426_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE albt-20230426_pre.xml EX-101.PRE 22375
8 EXTRACTED XBRL INSTANCE DOCUMENT ea177537-8k_avalon_htm.xml XML 3608
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

IRS No.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38728 | Film No.: 23857433
SIC: 2836 Biological Products, (No Diagnostic Substances)